FDA Approves Medtronic’s Brain Stimulation Surgery

Medtronic revealed that the FDA has approved its deep brain stimulation (DBS) procedure for patients with essential tremor (ET) and Parkinson’s disease. The massive medical technology business claims to be the sole and initial entity to receive FDA permission for performing DBS surgery on patients who are either awake or unconscious (under general anaesthesia).

Medtronic revealed studies that showed individuals with Parkinson’s disease who underwent either awake or asleep DBS surgery saw similar improvements in a few motor symptoms. Research conducted on sleeping DBS shown preserved patient security and possible surgical efficiency. This might result in a quicker process than with awake DBS.

Medtronic revealed a surgically inserted device, similar to a cardiac pacemaker, is used by DBS. The Percept neurostimulators, made available by Medtronic, provide electrical stimulation to certain brain regions impacted by neurological conditions using thin cables.

Amaza Reitmeier, VP and GM, Brain Modulation within the Neuromodulation business at Medtronic stated: “This is a significant advancement in our surgical offering, providing another safe and effective option for patients considering DBS.”

They continued: “This approval underscores our dedication to continuous innovation to address the needs of patients and healthcare providers.”